NL8701335A - Orale farmaceutische preparaten. - Google Patents

Orale farmaceutische preparaten. Download PDF

Info

Publication number
NL8701335A
NL8701335A NL8701335A NL8701335A NL8701335A NL 8701335 A NL8701335 A NL 8701335A NL 8701335 A NL8701335 A NL 8701335A NL 8701335 A NL8701335 A NL 8701335A NL 8701335 A NL8701335 A NL 8701335A
Authority
NL
Netherlands
Prior art keywords
minutes
percent
ketotifene
pharmaceutical composition
granular
Prior art date
Application number
NL8701335A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8701335A publication Critical patent/NL8701335A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8701335A 1986-06-21 1987-06-09 Orale farmaceutische preparaten. NL8701335A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3620830 1986-06-21
DE3620830 1986-06-21

Publications (1)

Publication Number Publication Date
NL8701335A true NL8701335A (nl) 1988-01-18

Family

ID=6303418

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701335A NL8701335A (nl) 1986-06-21 1987-06-09 Orale farmaceutische preparaten.

Country Status (30)

Country Link
US (1) US5399360A (fi)
JP (2) JPS638332A (fi)
KR (1) KR880000095A (fi)
AT (1) AT400521B (fi)
AU (1) AU611637B2 (fi)
BE (1) BE1000661A4 (fi)
CA (1) CA1314227C (fi)
CH (3) CH676201A5 (fi)
CY (1) CY1589A (fi)
DE (1) DE3719818C2 (fi)
DK (1) DK314387A (fi)
ES (1) ES2006170A6 (fi)
FI (1) FI872733A (fi)
FR (1) FR2600253B1 (fi)
GB (1) GB2191696B (fi)
GR (1) GR870965B (fi)
HK (1) HK27691A (fi)
HU (1) HU202753B (fi)
IE (1) IE59178B1 (fi)
IL (1) IL82924A (fi)
IT (1) IT1216822B (fi)
LU (1) LU86928A1 (fi)
MY (1) MY101566A (fi)
NL (1) NL8701335A (fi)
NO (1) NO872551L (fi)
NZ (1) NZ220769A (fi)
PH (1) PH26313A (fi)
PT (1) PT85128B (fi)
SE (1) SE8702563L (fi)
ZA (1) ZA874450B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
WO1998056381A1 (en) * 1997-06-09 1998-12-17 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
US6740889B1 (en) * 1998-09-28 2004-05-25 Applied Materials, Inc. Charged particle beam microscope with minicolumn
AU5139800A (en) * 1999-12-01 2001-06-12 Klein Pharmaceuticals Topical administration of ketotifen
US20030153620A1 (en) * 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ514536A (en) * 2001-09-28 2005-02-25 Meracol Corp Ltd Use of cetyl myristate and/or cetyl palmitate to treat asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
JP4867128B2 (ja) * 2002-10-01 2012-02-01 大正製薬株式会社 経口鼻炎治療用組成物
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
WO2009142772A2 (en) 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
EP2583673A1 (en) * 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
HUT40568A (en) * 1984-08-16 1987-01-28 Sandoz Ag Process for production of medical preparatives containing ketityphen and xantin-derivatives against asthma
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
SE8702563L (sv) 1987-12-22
JPS638332A (ja) 1988-01-14
NO872551L (no) 1987-12-22
IT8748075A0 (it) 1987-06-19
FR2600253B1 (fr) 1990-01-26
CH676201A5 (fi) 1990-12-28
FI872733A0 (fi) 1987-06-18
DE3719818C2 (de) 1997-02-13
HU202753B (en) 1991-04-29
MY101566A (en) 1991-12-17
PH26313A (en) 1992-04-23
GB2191696A (en) 1987-12-23
PT85128B (pt) 1990-03-30
IL82924A0 (en) 1987-12-20
AU7452587A (en) 1987-12-24
GB2191696B (en) 1991-01-16
KR880000095A (ko) 1988-03-23
FI872733A (fi) 1987-12-22
DE3719818A1 (de) 1987-12-23
GR870965B (en) 1987-10-20
CH672735A5 (fi) 1989-12-29
JP2860013B2 (ja) 1999-02-24
LU86928A1 (fr) 1988-01-20
BE1000661A4 (fr) 1989-03-07
NO872551D0 (no) 1987-06-18
DK314387D0 (da) 1987-06-19
IL82924A (en) 1992-11-15
HK27691A (en) 1991-04-19
IE871634L (en) 1987-12-21
ZA874450B (en) 1989-01-25
IE59178B1 (en) 1994-01-26
SE8702563D0 (sv) 1987-06-18
IT1216822B (it) 1990-03-14
ATA156187A (de) 1995-06-15
CH674805A5 (fi) 1990-07-31
GB8714131D0 (en) 1987-07-22
FR2600253A1 (fr) 1987-12-24
JPH05246849A (ja) 1993-09-24
AU611637B2 (en) 1991-06-20
US5399360A (en) 1995-03-21
CA1314227C (en) 1993-03-09
PT85128A (en) 1987-07-01
ES2006170A6 (es) 1989-04-16
HUT47428A (en) 1989-03-28
CY1589A (en) 1992-04-03
NZ220769A (en) 1990-12-21
AT400521B (de) 1996-01-25
DK314387A (da) 1987-12-22

Similar Documents

Publication Publication Date Title
AU2019204689B2 (en) Solid dosage forms of palbociclib
NL8701335A (nl) Orale farmaceutische preparaten.
KR101151011B1 (ko) 테노포비어, 계면 활성제, 에파비렌즈와 엠트리씨타빈을함유하는, 안정한 고정 투여량의 단위 제형
US7741374B1 (en) Methods of use of fenofibric acid
KR101181172B1 (ko) 방출성이 제어된 시간차 투여 약제학적 제제
US20120015032A1 (en) Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
EA037375B1 (ru) Составы с замедленным высвобождением, содержащие колхицин, и способы их применения
NL8501578A (nl) Nieuwe galenische retardvorm.
RU2724338C2 (ru) Фармацевтическая комплексная композиция, включающая амлодипин, лозартан и розувастатин
KR20090015890A (ko) 저 홍조 니아신 제형
BG64839B1 (bg) Контролирано освобождаващи перорални състави на левосимендан
JP4945043B2 (ja) モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤
NL194822C (nl) Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
KR102391495B1 (ko) 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제
EP3727344A1 (en) Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물
EP3184101A1 (en) Levodopa and carbidopa modified release composition
WO2024047208A1 (en) Anticoagulant therapy with an improved dosage regimen
CA2632198C (en) Pharmaceutical formulation containing phenytoin sodium and magnesium stearate

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: NOVARTIS AG

BV The patent application has lapsed